If switching is not possible: Consider increasing oral progesterone from 100 mg to 200 mg daily for the first 4 weeks of GLP-1 treatment, per clinical guidance
"With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of 'no-reflow' in heart attack patients, offering a potentially life-saving solution," said University College London Professor David Atwell
GHK-Cu and Skin Renewal GHK-Cu is a naturally occurring copper-binding peptide often discussed in connection with skin quality, tissue remodeling, and wound-healing biology
It catches concentration mix-ups, arithmetic errors, syringe misreads, and dose escalation mistakes
Heather and Dr Lazarus are wonderful
Traveling with reconstituted peptides Taking peptides on trips requires planning